Satellite Symposium - Changing perspectives on the role of the immune system in multiple sclerosis: pathology, differentiation, and targeted therapies
ECTRIMS Learn. Presenters F. 09/14/16; 147371; 301
Faculty / Presenters
Abstract
Chairs
H.-P. Hartung, Düsseldorf, Germany
Supported by Vindico with an independent educational grant from Roche
Presentations
80 - Introduction and Pretest
H.-P. Hartung, Düsseldorf, Germany
17:30 – 17:35
81 - Differentiating disease and the role of the immune system
G. Comi, Milan, Italy
17:35 – 17:50
82 - Dissecting the data on new and emerging high-efficacy agents for RRMS and PPMS
S. Hauser, San Francisco, United States
17:50 – 18:05
83 - Best practices when using selective high-efficacy agents
X. Montalban, Barcelona, Spain
18:05 – 18:20
84 - Posttest
18:20 – 18:25
85 - Question and Answer
18:25 – 18:30
H.-P. Hartung, Düsseldorf, Germany
Supported by Vindico with an independent educational grant from Roche
Presentations
80 - Introduction and Pretest
H.-P. Hartung, Düsseldorf, Germany
17:30 – 17:35
81 - Differentiating disease and the role of the immune system
G. Comi, Milan, Italy
17:35 – 17:50
82 - Dissecting the data on new and emerging high-efficacy agents for RRMS and PPMS
S. Hauser, San Francisco, United States
17:50 – 18:05
83 - Best practices when using selective high-efficacy agents
X. Montalban, Barcelona, Spain
18:05 – 18:20
84 - Posttest
18:20 – 18:25
85 - Question and Answer
18:25 – 18:30
Chairs
H.-P. Hartung, Düsseldorf, Germany
Supported by Vindico with an independent educational grant from Roche
Presentations
80 - Introduction and Pretest
H.-P. Hartung, Düsseldorf, Germany
17:30 – 17:35
81 - Differentiating disease and the role of the immune system
G. Comi, Milan, Italy
17:35 – 17:50
82 - Dissecting the data on new and emerging high-efficacy agents for RRMS and PPMS
S. Hauser, San Francisco, United States
17:50 – 18:05
83 - Best practices when using selective high-efficacy agents
X. Montalban, Barcelona, Spain
18:05 – 18:20
84 - Posttest
18:20 – 18:25
85 - Question and Answer
18:25 – 18:30
H.-P. Hartung, Düsseldorf, Germany
Supported by Vindico with an independent educational grant from Roche
Presentations
80 - Introduction and Pretest
H.-P. Hartung, Düsseldorf, Germany
17:30 – 17:35
81 - Differentiating disease and the role of the immune system
G. Comi, Milan, Italy
17:35 – 17:50
82 - Dissecting the data on new and emerging high-efficacy agents for RRMS and PPMS
S. Hauser, San Francisco, United States
17:50 – 18:05
83 - Best practices when using selective high-efficacy agents
X. Montalban, Barcelona, Spain
18:05 – 18:20
84 - Posttest
18:20 – 18:25
85 - Question and Answer
18:25 – 18:30
{{ help_message }}
{{filter}}